SYNB vs. HRTS ETF Comparison

Comparison of Putnam BioRevolution ETF (SYNB) to Tema Cardiovascular and Metabolic ETF (HRTS)
SYNB

Putnam BioRevolution ETF

SYNB Description

Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. Putnam BioRevolution ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$30.42

Average Daily Volume

211

Number of Holdings *

9

* may have additional holdings in another (foreign) market
HRTS

Tema Cardiovascular and Metabolic ETF

HRTS Description Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$32.34

Average Daily Volume

28,898

Number of Holdings *

9

* may have additional holdings in another (foreign) market
Performance
Period SYNB HRTS
30 Days 0.21% -2.15%
60 Days -1.52% -5.66%
90 Days 3.29% 0.90%
12 Months 11.31%
2 Overlapping Holdings
Symbol Grade Weight in SYNB Weight in HRTS Overlap
ASND D 3.93% 2.76% 2.76%
LLY C 3.57% 5.03% 3.57%
Compare ETFs